{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T15:28:51Z","timestamp":1789140531624,"version":"build-2803163510"},"reference-count":218,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.bbrc.2024.150664","type":"journal-article","created":{"date-parts":[[2024,9,4]],"date-time":"2024-09-04T06:21:41Z","timestamp":1725430901000},"page":"150664","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Chromosomal and cellular therapeutic approaches for Down syndrome: A research update"],"prefix":"10.1016","volume":"735","author":[{"given":"Tan","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharida","family":"Fakurazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2181-2502","authenticated-orcid":false,"given":"Pike-See","family":"Cheah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3968-7263","authenticated-orcid":false,"given":"King-Hwa","family":"Ling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2024.150664_bib1","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1056\/NEJMra1706537","article-title":"Down syndrome","volume":"382","author":"Bull","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbrc.2024.150664_bib2","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2016-0123","article-title":"Trends in congenital heart defects in infants with down syndrome","volume":"138","author":"Bergstr\u00f6m","year":"2016","journal-title":"Pediatrics"},{"key":"10.1016\/j.bbrc.2024.150664_bib3","doi-asserted-by":"crossref","DOI":"10.53350\/pjmhs22169582","article-title":"A prospective study on prevalence of conginetal heart diseases in children with down syndrome","volume":"16","author":"Bilal","year":"2022","journal-title":"Pakistan Journal of Medical & Health Sciences"},{"key":"10.1016\/j.bbrc.2024.150664_bib4","first-page":"172","article-title":"Genomic landscape of Down syndrome-associated acute lymphoblastic leukemia","volume":"142","author":"Li","year":"2023","journal-title":"Blood"},{"key":"10.1016\/j.bbrc.2024.150664_bib5","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/S1474-4422(10)70112-5","article-title":"Cognitive deficits and associated neurological complications in individuals with Down's syndrome","volume":"9","author":"Lott","year":"2010","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.bbrc.2024.150664_bib6","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1111\/dmcn.14260","article-title":"New approaches to studying early brain development in Down syndrome","volume":"61","author":"Baburamani","year":"2019","journal-title":"Dev. Med. Child Neurol."},{"key":"10.1016\/j.bbrc.2024.150664_bib7","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.3324\/haematol.2023.283225","article-title":"Down syndrome and leukemia: from basic mechanisms to clinical advances","volume":"108","author":"Baruchel","year":"2023","journal-title":"Haematologica"},{"key":"10.1016\/j.bbrc.2024.150664_bib8","doi-asserted-by":"crossref","first-page":"4430","DOI":"10.1038\/ncomms5430","article-title":"Role of astroglia in Down's syndrome revealed by patient-derived human-induced pluripotent stem cells","volume":"5","author":"Chen","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbrc.2024.150664_bib9","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.neuron.2020.11.017","article-title":"Mitigating cognitive deficits in down syndrome by managing microglia activation","volume":"108","author":"Shaw","year":"2020","journal-title":"Neuron"},{"key":"10.1016\/j.bbrc.2024.150664_bib10","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1002\/acr.24418","article-title":"CARRA registry investigators, down syndrome-associated arthritis cohort in the new childhood arthritis and rheumatology research alliance registry: clinical characteristics, treatment, and outcomes","volume":"73","author":"Jones","year":"2021","journal-title":"Arthritis Care Res."},{"key":"10.1016\/j.bbrc.2024.150664_bib11","doi-asserted-by":"crossref","first-page":"5938","DOI":"10.1523\/JNEUROSCI.1547-09.2009","article-title":"The \u201cDown syndrome critical region\u201d is sufficient in the mouse model to confer behavioral, neurophysiological, and synaptic phenotypes characteristic of Down syndrome","volume":"29","author":"Belichenko","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbrc.2024.150664_bib12","doi-asserted-by":"crossref","first-page":"12031","DOI":"10.1073\/pnas.0813248106","article-title":"The genetic architecture of Down syndrome phenotypes revealed by high-resolution analysis of human segmental trisomies","volume":"106","author":"Korbel","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbrc.2024.150664_bib13","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/ejhg.2008.214","article-title":"Genotype-phenotype correlations in Down syndrome identified by array CGH in 30 cases of partial trisomy and partial monosomy chromosome 21","volume":"17","author":"Lyle","year":"2009","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.bbrc.2024.150664_bib14","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1016\/j.ajhg.2022.10.014","article-title":"Consequences of chromosome gain: a new view on trisomy syndromes","volume":"109","author":"Krivega","year":"2022","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.bbrc.2024.150664_bib15","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/ajmg.1320140206","article-title":"Down syndrome\u2014a disruption of homeostasis","volume":"14","author":"Shapiro","year":"1983","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.bbrc.2024.150664_bib16","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/ana.410430316","article-title":"Molecular mapping of Alzheimer-type dementia in Down's syndrome","volume":"43","author":"Prasher","year":"1998","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bbrc.2024.150664_bib17","doi-asserted-by":"crossref","first-page":"459","DOI":"10.3233\/JAD-160836","article-title":"Down syndrome, partial trisomy 21, and absence of alzheimer's disease: the role of APP","volume":"56","author":"Doran","year":"2017","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.bbrc.2024.150664_bib18","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1093\/hmg\/ddp047","article-title":"DYRK1A interacts with the REST\/NRSF-SWI\/SNF chromatin remodelling complex to deregulate gene clusters involved in the neuronal phenotypic traits of Down syndrome","volume":"18","author":"Marie Lepagnol-Bestel","year":"2009","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbrc.2024.150664_bib19","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1038\/nn.2600","article-title":"Olig1 and Olig2 triplication causes developmental brain defects in Down syndrome","volume":"13","author":"Chakrabarti","year":"2010","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.bbrc.2024.150664_bib20","article-title":"S100B and APP promote a gliocentric shift and impaired neurogenesis in down syndrome neural progenitors","volume":"6","author":"Lu","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.bbrc.2024.150664_bib21","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.stem.2019.04.014","article-title":"OLIG2 drives abnormal neurodevelopmental phenotypes in human iPSC-based organoid and chimeric mouse models of down syndrome","volume":"24","author":"Xu","year":"2019","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.bbrc.2024.150664_bib22","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0140-6736(99)05264-2","article-title":"Risks of leukaemia and solid tumours in individuals with Down's syndrome","volume":"355","author":"Hasle","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.bbrc.2024.150664_bib23","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.27700","article-title":"Development of acute lymphoblastic leukemia following treatment for acute myeloid leukemia in children with Down syndrome: a case report and retrospective review of Children's Oncology Group acute myeloid leukemia trials","volume":"66","author":"Murphy","year":"2019","journal-title":"Pediatr. Blood Cancer"},{"key":"10.1016\/j.bbrc.2024.150664_bib24","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrc1525","article-title":"Origins of leukaemia in children with Down syndrome","volume":"5","author":"Hitzler","year":"2005","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bbrc.2024.150664_bib25","doi-asserted-by":"crossref","first-page":"3337","DOI":"10.1182\/blood-2008-08-174813","article-title":"ETS2 and ERG promote megakaryopoiesis and synergize with alterations in GATA-1 to immortalize hematopoietic progenitor cells","volume":"113","author":"Stankiewicz","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.bbrc.2024.150664_bib26","doi-asserted-by":"crossref","first-page":"2928","DOI":"10.1182\/blood-2009-06-227629","article-title":"Perturbed hematopoiesis in the Tc1 mouse model of Down syndrome","volume":"115","author":"Alford","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.bbrc.2024.150664_bib27","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/ng955","article-title":"Acquired mutations in GATA1 in the megakaryoblastic leukemia of Down syndrome","volume":"32","author":"Wechsler","year":"2002","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbrc.2024.150664_bib28","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0098-2016","article-title":"What people with Down Syndrome can teach us about cardiopulmonary disease","volume":"26","author":"Colvin","year":"2017","journal-title":"Eur. Respir. Rev."},{"key":"10.1016\/j.bbrc.2024.150664_bib29","doi-asserted-by":"crossref","first-page":"4309","DOI":"10.1038\/s41598-018-22342-5","article-title":"Muscle stem cell dysfunction impairs muscle regeneration in a mouse model of Down syndrome","volume":"8","author":"Pawlikowski","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbrc.2024.150664_bib30","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1016\/j.celrep.2016.04.031","article-title":"Systematic cellular disease models reveal synergistic interaction of trisomy 21 and GATA1 mutations in hematopoietic abnormalities","volume":"15","author":"Banno","year":"2016","journal-title":"Cell Rep."},{"key":"10.1016\/j.bbrc.2024.150664_bib31","doi-asserted-by":"crossref","first-page":"961","DOI":"10.4103\/1673-5374.382245","article-title":"New insights into the effects of APP gene dose on synapse in Down syndrome","volume":"19","author":"Chen","year":"2024","journal-title":"Neural Regeneration Research"},{"key":"10.1016\/j.bbrc.2024.150664_bib32","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.devcel.2019.12.015","article-title":"Silencing trisomy 21 with XIST in neural stem cells promotes neuronal differentiation","volume":"52","author":"Czermi\u0144ski","year":"2020","journal-title":"Dev. Cell"},{"key":"10.1016\/j.bbrc.2024.150664_bib33","doi-asserted-by":"crossref","first-page":"3655","DOI":"10.3390\/ijms24043655","article-title":"High-efficiency CRISPR\/Cas9-Mediated correction of a homozygous mutation in achromatopsia-patient-derived iPSCs","volume":"24","author":"Siles","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbrc.2024.150664_bib34","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1038\/nature12394","article-title":"Translating dosage compensation to trisomy 21","volume":"500","author":"Jiang","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2024.150664_bib35","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1038\/s41374-019-0230-0","article-title":"Autonomous trisomic rescue of Down syndrome cells","volume":"99","author":"Inoue","year":"2019","journal-title":"Lab. Invest."},{"key":"10.1016\/j.bbrc.2024.150664_bib36","doi-asserted-by":"crossref","first-page":"9962","DOI":"10.1073\/pnas.1216575110","article-title":"Deficits in human trisomy 21 iPSCs and neurons","volume":"110","author":"Weick","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbrc.2024.150664_bib37","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/gim.2016.127","article-title":"Estimation of the number of people with Down syndrome in the United States","volume":"19","author":"de Graaf","year":"2017","journal-title":"Genet. Med."},{"key":"10.1016\/j.bbrc.2024.150664_bib38","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/s41431-020-00748-y","article-title":"Estimation of the number of people with Down syndrome in Europe","volume":"29","author":"de Graaf","year":"2021","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.bbrc.2024.150664_bib39","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.3390\/children9091329","article-title":"Long-term observational outcomes after total correction of congenital heart disease in Korean patients with down syndrome: a national cohort study","volume":"9","author":"Kwak","year":"2022","journal-title":"Children"},{"key":"10.1016\/j.bbrc.2024.150664_bib40","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1159\/000154261","article-title":"Down's syndrome in Saudi Arabia: incidence and cytogenetics","volume":"45","author":"Niazi","year":"1995","journal-title":"Hum. Hered."},{"key":"10.1016\/j.bbrc.2024.150664_bib41","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1002\/ajmg.a.61298","article-title":"Equipoise of recent estimated Down syndrome live births in Japan","volume":"179","author":"Sasaki","year":"2019","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.bbrc.2024.150664_bib42","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1002\/ajmg.a.61044","article-title":"Prevalence and risk factors for Down syndrome: a hospital-based single-center study in Western Mexico","volume":"179","author":"Corona-Rivera","year":"2019","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.bbrc.2024.150664_bib43","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41572-019-0143-7","article-title":"Down syndrome","volume":"6","author":"Antonarakis","year":"2020","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.bbrc.2024.150664_bib44","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s12687-022-00627-7","article-title":"Mothers of children with Down syndrome: a clinical and epidemiological study","volume":"14","author":"Aprigio","year":"2023","journal-title":"J Community Genet"},{"key":"10.1016\/j.bbrc.2024.150664_bib45","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/s41431-023-01330-y","article-title":"Down syndrome screening and diagnosis practices in Europe, United States, Australia, and New Zealand from 1990\u20132021","volume":"31","author":"Wilmot","year":"2023","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.bbrc.2024.150664_bib46","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.jpeds.2007.07.045","article-title":"Is Down syndrome a disappearing birth defect?","volume":"152","author":"Collins","year":"2008","journal-title":"J. Pediatr."},{"key":"10.1016\/j.bbrc.2024.150664_bib47","doi-asserted-by":"crossref","first-page":"b3794","DOI":"10.1136\/bmj.b3794","article-title":"Trends in down's syndrome live births and antenatal diagnoses in England and wales from 1989 to 2008: analysis of data from the national down syndrome cytogenetic register","volume":"339","author":"Morris","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.bbrc.2024.150664_bib48","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1002\/uog.4775","article-title":"P31.05: incidence of Down syndrome in Slovenia in the last 15 years","volume":"30","author":"Tul","year":"2007","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"10.1016\/j.bbrc.2024.150664_bib49","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/pd.4516","article-title":"Recent trends in the birth prevalence of Down syndrome in China: impact of prenatal diagnosis and subsequent terminations","volume":"35","author":"Deng","year":"2015","journal-title":"Prenat. Diagn."},{"key":"10.1016\/j.bbrc.2024.150664_bib50","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1002\/bdr2.1975","article-title":"National Birth Defects Prevention Network, Co-occurrence of congenital anomalies by maternal race\/ethnicity among infants and fetuses with Down syndrome, 2013-2017: a U.S. population-based analysis","volume":"114","author":"Stallings","year":"2022","journal-title":"Birth Defects Res"},{"key":"10.1016\/j.bbrc.2024.150664_bib51","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1002\/bdr2.1553","article-title":"Down syndrome among primiparae at older maternal age: a test of the relaxed filter hypothesis","volume":"111","author":"Bruckner","year":"2019","journal-title":"Birth Defects Res"},{"key":"10.1016\/j.bbrc.2024.150664_bib52","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s00114-006-0165-3","article-title":"Adaptive-filtering of trisomy 21: risk of Down syndrome depends on family size and age of previous child","volume":"94","author":"Neuh\u00e4user","year":"2007","journal-title":"Naturwissenschaften"},{"key":"10.1016\/j.bbrc.2024.150664_bib53","series-title":"Chromosome Abnormalities and Genetic Counseling","author":"Gardner","year":"2012"},{"key":"10.1016\/j.bbrc.2024.150664_bib54","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1159\/000056844","article-title":"Nondisjunction in trisomy 21: origin and mechanisms","volume":"91","author":"Petersen","year":"2000","journal-title":"Cytogenet. Cell Genet."},{"key":"10.1016\/j.bbrc.2024.150664_bib55","first-page":"628","article-title":"Advanced maternal age and the risk of Down syndrome characterized by the meiotic stage of chromosomal error: a population-based study","volume":"58","author":"Yoon","year":"1996","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.bbrc.2024.150664_bib56","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/ajmg.a.36861","article-title":"Mosaicism for trisomy 21: a review","volume":"167A","author":"Papavassiliou","year":"2015","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.bbrc.2024.150664_bib57","first-page":"2525","article-title":"Systematic reanalysis of partial trisomy 21 cases with or without Down syndrome suggests a small region on 21q22.13 as critical to the phenotype","volume":"25","author":"Pelleri","year":"2016","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbrc.2024.150664_bib58","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/nature11212","article-title":"An expansive human regulatory lexicon encoded in transcription factor footprints","volume":"489","author":"Neph","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2024.150664_bib59","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/nature09906","article-title":"Mapping and analysis of chromatin state dynamics in nine human cell types","volume":"473","author":"Ernst","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2024.150664_bib60","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1101\/gr.135350.111","article-title":"GENCODE: the reference human genome annotation for the ENCODE Project","volume":"22","author":"Harrow","year":"2012","journal-title":"Genome Res."},{"key":"10.1016\/j.bbrc.2024.150664_bib61","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1038\/s41467-017-01422-6","article-title":"Systematic proteome and proteostasis profiling in human Trisomy 21 fibroblast cells","volume":"8","author":"Liu","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbrc.2024.150664_bib62","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1002\/alz.12463","article-title":"Impact of increased APP gene dose in Down syndrome and the Dp16 mouse model","volume":"18","author":"Sawa","year":"2022","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.bbrc.2024.150664_bib63","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0219592","article-title":"Elimination of protein aggregates prevents premature senescence in human trisomy 21 fibroblasts","volume":"14","author":"Nawa","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.bbrc.2024.150664_bib64","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s00401-016-1577-6","article-title":"Intraneuronal aggregation of the \u03b2-CTF fragment of APP (C99) induces A\u03b2-independent lysosomal-autophagic pathology","volume":"132","author":"Lauritzen","year":"2016","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.bbrc.2024.150664_bib65","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s42003-021-02278-9","article-title":"Genotoxic stress in constitutive trisomies induces autophagy and the innate immune response via the cGAS-STING pathway","volume":"4","author":"Krivega","year":"2021","journal-title":"Commun. Biol."},{"key":"10.1016\/j.bbrc.2024.150664_bib66","article-title":"Amyloid precursor protein (APP) regulates gliogenesis and neurogenesis of human neural stem cells by several signaling pathways","volume":"24","author":"Coronel","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbrc.2024.150664_bib67","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.neuron.2006.05.022","article-title":"Increased App expression in a mouse model of Down's syndrome disrupts NGF transport and causes cholinergic neuron degeneration","volume":"51","author":"Salehi","year":"2006","journal-title":"Neuron"},{"key":"10.1016\/j.bbrc.2024.150664_bib68","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1038\/s41380-022-01454-5","article-title":"APP and DYRK1A regulate axonal and synaptic vesicle protein networks and mediate Alzheimer's pathology in trisomy 21 neurons","volume":"27","author":"Wu","year":"2022","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.bbrc.2024.150664_bib69","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1186\/s12915-023-01700-4","article-title":"Transcription dosage compensation does not occur in Down syndrome","volume":"21","author":"Hunter","year":"2023","journal-title":"BMC Biol."},{"key":"10.1016\/j.bbrc.2024.150664_bib70","doi-asserted-by":"crossref","first-page":"125","DOI":"10.3389\/fgene.2018.00125","article-title":"Integrated quantitative transcriptome maps of human trisomy 21 tissues and cells","volume":"9","author":"Pelleri","year":"2018","journal-title":"Front. Genet."},{"key":"10.1016\/j.bbrc.2024.150664_bib71","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1186\/1471-2164-15-139","article-title":"Unique features of the transcriptional response to model aneuploidy in human cells","volume":"15","author":"D\u00fcrrbaum","year":"2014","journal-title":"BMC Genom."},{"key":"10.1016\/j.bbrc.2024.150664_bib72","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1038\/msb.2012.40","article-title":"Global analysis of genome, transcriptome and proteome reveals the response to aneuploidy in human cells","volume":"8","author":"Stingele","year":"2012","journal-title":"Mol. Syst. Biol."},{"key":"10.1016\/j.bbrc.2024.150664_bib73","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.ajhg.2008.08.012","article-title":"DYRK1A-Dosage imbalance perturbs NRSF\/REST levels, deregulating pluripotency and embryonic stem cell fate in down syndrome","volume":"83","author":"Canzonetta","year":"2008","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.bbrc.2024.150664_bib74","article-title":"Spatiotemporal expression of Rest in the brain of Ts1Cje mouse model of Down syndrome","author":"Lim","year":"2023","journal-title":"Review"},{"key":"10.1016\/j.bbrc.2024.150664_bib75","doi-asserted-by":"crossref","first-page":"9980","DOI":"10.3390\/ijms24129980","article-title":"REST targets JAK\u2013STAT and HIF-1 signaling pathways in human down syndrome brain and neural cells","volume":"24","author":"Huang","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbrc.2024.150664_bib76","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0194581","article-title":"Transcriptome analysis of genetically matched human induced pluripotent stem cells disomic or trisomic for chromosome 21","volume":"13","author":"Gonzales","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.bbrc.2024.150664_bib77","doi-asserted-by":"crossref","first-page":"6539","DOI":"10.1038\/s41598-019-42990-5","article-title":"The nuclear interactome of DYRK1A reveals a functional role in DNA damage repair","volume":"9","author":"Guard","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbrc.2024.150664_bib78","doi-asserted-by":"crossref","first-page":"6014","DOI":"10.1038\/s41598-019-42445-x","article-title":"A comprehensive proteomics-based interaction screen that links DYRK1A to RNF169 and to the DNA damage response","volume":"9","author":"Roewenstrunk","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbrc.2024.150664_bib79","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.molcel.2012.03.021","article-title":"Roles of Mis18\u03b1 in epigenetic regulation of centromeric chromatin and CENP-A loading","volume":"46","author":"Kim","year":"2012","journal-title":"Mol. Cell."},{"key":"10.1016\/j.bbrc.2024.150664_bib80","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1186\/s13059-015-0827-6","article-title":"Trans effects of chromosome aneuploidies on DNA methylation patterns in human Down syndrome and mouse models","volume":"16","author":"Mendioroz","year":"2015","journal-title":"Genome Biol."},{"key":"10.1016\/j.bbrc.2024.150664_bib81","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1006\/geno.1997.5190","article-title":"Identification and characterization of two putative human arginine methyltransferases (HRMT1L1 and HRMT1L2)","volume":"48","author":"Scott","year":"1998","journal-title":"Genomics"},{"key":"10.1016\/j.bbrc.2024.150664_bib82","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.molcel.2018.06.015","article-title":"N6-Methyladenine DNA modification in the human genome","volume":"71","author":"Xiao","year":"2018","journal-title":"Mol. Cell."},{"key":"10.1016\/j.bbrc.2024.150664_bib83","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.tig.2022.11.004","article-title":"Consequences of trisomy syndromes \u2013 21 and beyond","volume":"39","author":"Krivega","year":"2023","journal-title":"Trends Genet."},{"key":"10.1016\/j.bbrc.2024.150664_bib84","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0254806","article-title":"Trisomy 21-associated increases in chromosomal instability are unmasked by comparing isogenic trisomic\/disomic leukocytes from people with mosaic Down syndrome","volume":"16","author":"Rafferty","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.bbrc.2024.150664_bib85","doi-asserted-by":"crossref","unstructured":"M. Kneissig, K. Keuper, M.S. de Pagter, M.J. van Roosmalen, J. Martin, H. Otto, V. Passerini, A. Campos Sparr, I. Renkens, F. Kropveld, A. Vasudevan, J.M. Sheltzer, W.P. Kloosterman, Z. Storchova, Micronuclei-based model system reveals functional consequences of chromothripsis in human cells, Elife 8 (n.d.) e50292. https:\/\/doi.org\/10.7554\/eLife.50292.","DOI":"10.7554\/eLife.50292"},{"key":"10.1016\/j.bbrc.2024.150664_bib86","first-page":"1","article-title":"Genomic instability in individuals with sex determination defects and germ cell cancer","volume":"9","author":"Krivega","year":"2023","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbrc.2024.150664_bib87","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.humpath.2005.09.021","article-title":"Maturation delay of germ cells in fetuses with trisomy 21 results in increased risk for the development of testicular germ cell tumors","volume":"37","author":"Cools","year":"2006","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.bbrc.2024.150664_bib88","doi-asserted-by":"crossref","DOI":"10.1038\/srep43331","article-title":"Efficient and rapid generation of large genomic variants in rats and mice using CRISMERE","volume":"7","author":"Birling","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbrc.2024.150664_bib89","article-title":"DSCAM\/PAK1 pathway suppression reverses neurogenesis deficits in iPSC-derived cerebral organoids from patients with Down syndrome","volume":"131","author":"Tang","year":"2017","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbrc.2024.150664_bib90","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1186\/s13059-017-1354-4","article-title":"CRISPR\/Cas9-mediated targeted chromosome elimination","volume":"18","author":"Zuo","year":"2017","journal-title":"Genome Biol."},{"key":"10.1016\/j.bbrc.2024.150664_bib91","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.omtm.2020.09.007","article-title":"Modeling transient abnormal myelopoiesis using induced pluripotent stem cells and CRISPR\/Cas9 technology","volume":"19","author":"Barwe","year":"2020","journal-title":"Mol Ther Methods Clin Dev"},{"key":"10.1016\/j.bbrc.2024.150664_bib92","doi-asserted-by":"crossref","first-page":"628","DOI":"10.3390\/cells11040628","article-title":"Modeling down syndrome myeloid leukemia by sequential introduction of GATA1 and STAG2 mutations in induced pluripotent stem cells with trisomy 21","volume":"11","author":"Barwe","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.bbrc.2024.150664_bib93","article-title":"A trisomy 21-linked hematopoietic gene variant in microglia confers resilience in human iPSC models of alzheimer's disease","author":"Jin","year":"2024","journal-title":"bioRxiv"},{"key":"10.1016\/j.bbrc.2024.150664_bib94","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2023.104692","article-title":"Dose imbalance of DYRK1A kinase causes systemic progeroid status in Down syndrome by increasing the un-repaired DNA damage and reducing LaminB1 levels","volume":"94","author":"Murray","year":"2023","journal-title":"EBioMedicine"},{"key":"10.1016\/j.bbrc.2024.150664_bib95","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1126\/science.1098992","article-title":"A chromosome 21 critical region does not cause specific down syndrome phenotypes","volume":"306","author":"Olson","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.bbrc.2024.150664_bib96","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/6037159","article-title":"Engineering of systematic elimination of a targeted chromosome in human cells","volume":"2017","author":"Sato","year":"2017","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.bbrc.2024.150664_bib97","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1038\/s41598-017-00714-7","article-title":"A pair of maternal chromosomes derived from meiotic nondisjunction in trisomy 21 affects nuclear architecture and transcriptional regulation","volume":"7","author":"Omori","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbrc.2024.150664_bib98","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s13229-017-0168-2","article-title":"Zebrafish knockout of Down syndrome gene, DYRK1A, shows social impairments relevant to autism","volume":"8","author":"Kim","year":"2017","journal-title":"Mol. Autism."},{"key":"10.1016\/j.bbrc.2024.150664_bib99","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1182\/blood.V124.21.868.868","article-title":"Exploring the pathogenesis of down syndrome-related myeloproliferative disorders using iPSCs","volume":"124","author":"Yoko","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.bbrc.2024.150664_bib100","doi-asserted-by":"crossref","first-page":"5180","DOI":"10.1038\/s41467-018-07630-y","article-title":"Trisomy silencing by XIST normalizes Down syndrome cell pathogenesis demonstrated for hematopoietic defects in vitro","volume":"9","author":"Chiang","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbrc.2024.150664_bib101","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s42003-021-02242-7","article-title":"A human isogenic iPSC-derived cell line panel identifies major regulators of aberrant astrocyte proliferation in Down syndrome","volume":"4","author":"Kawatani","year":"2021","journal-title":"Commun. Biol."},{"key":"10.1016\/j.bbrc.2024.150664_bib102","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.112686","article-title":"Early chromosome condensation by XIST builds A-repeat RNA density that facilitates gene silencing","volume":"42","author":"Valledor","year":"2023","journal-title":"Cell Rep."},{"key":"10.1016\/j.bbrc.2024.150664_bib103","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.111174","article-title":"Chromosome silencing in vitro reveals trisomy 21 causes cell-autonomous deficits in angiogenesis and early dysregulation in Notch signaling","volume":"40","author":"Moon","year":"2022","journal-title":"Cell Rep."},{"key":"10.1016\/j.bbrc.2024.150664_bib104","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1126\/science.1225829","article-title":"A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity","volume":"337","author":"Jinek","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.bbrc.2024.150664_bib105","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1002\/jcp.30064","article-title":"CRISPR\/Cas gene therapy","volume":"236","author":"Zhang","year":"2021","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.bbrc.2024.150664_bib106","doi-asserted-by":"crossref","DOI":"10.26508\/lsa.201800267","article-title":"CRISPR-induced double-strand breaks trigger recombination between homologous chromosome arms","volume":"2","author":"Brunner","year":"2019","journal-title":"Life Sci. Alliance"},{"key":"10.1016\/j.bbrc.2024.150664_bib107","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1016\/j.ymthe.2017.05.021","article-title":"Targeted deletion of an entire chromosome using CRISPR\/Cas9","volume":"25","author":"Adikusuma","year":"2017","journal-title":"Mol. Ther."},{"key":"10.1016\/j.bbrc.2024.150664_bib108","doi-asserted-by":"crossref","first-page":"3264","DOI":"10.1021\/acssynbio.2c00174","article-title":"Direct transfer and consolidation of synthetic yeast chromosomes by abortive mating and chromosome elimination","volume":"11","author":"Guo","year":"2022","journal-title":"ACS Synth. Biol."},{"key":"10.1016\/j.bbrc.2024.150664_bib109","doi-asserted-by":"crossref","first-page":"3728","DOI":"10.1038\/ncomms4728","article-title":"Targeted genomic rearrangements using CRISPR\/Cas technology","volume":"5","author":"Choi","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbrc.2024.150664_bib110","article-title":"Induction of site-specific chromosomal translocations in embryonic stem cells by CRISPR\/Cas9","volume":"6","author":"Jiang","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbrc.2024.150664_bib111","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms10770","article-title":"Multiplexed pancreatic genome engineering and cancer induction by transfection-based CRISPR\/Cas9 delivery in mice","volume":"7","author":"Maresch","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbrc.2024.150664_bib112","doi-asserted-by":"crossref","first-page":"3964","DOI":"10.1038\/ncomms4964","article-title":"Engineering human tumour-associated chromosomal translocations with the RNA-guided CRISPR-Cas9 system","volume":"5","author":"Torres","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbrc.2024.150664_bib113","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.omtn.2017.04.009","article-title":"CRISPR\/Cas9-Directed reassignment of the GATA1 initiation codon in K562 cells to recapitulate AML in down syndrome","volume":"7","author":"Bloh","year":"2017","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.bbrc.2024.150664_bib114","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1016\/j.cell.2013.05.028","article-title":"Jpx RNA activates Xist by evicting CTCF","volume":"153","author":"Sun","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.bbrc.2024.150664_bib115","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/s41594-022-00739-1","article-title":"Xist spatially amplifies SHARP\/SPEN recruitment to balance chromosome-wide silencing and specificity to the X chromosome","volume":"29","author":"Jachowicz","year":"2022","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.bbrc.2024.150664_bib116","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1008333","article-title":"Xist RNA in action: past, present, and future","volume":"15","author":"Loda","year":"2019","journal-title":"PLoS Genet."},{"key":"10.1016\/j.bbrc.2024.150664_bib117","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.devcel.2005.05.015","article-title":"Tsix silences Xist through modification of chromatin structure","volume":"9","author":"Sado","year":"2005","journal-title":"Dev. Cell"},{"key":"10.1016\/j.bbrc.2024.150664_bib118","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1080\/15476286.2015.1137420","article-title":"D-repeat in the XIST gene is required for X chromosome inactivation","volume":"13","author":"Lv","year":"2016","journal-title":"RNA Biol."},{"key":"10.1016\/j.bbrc.2024.150664_bib119","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.651648","article-title":"Cucurbitacin B inhibits cell proliferation by regulating X-inactive specific transcript expression in tongue cancer","volume":"11","author":"Tao","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bbrc.2024.150664_bib120","doi-asserted-by":"crossref","first-page":"e26","DOI":"10.1093\/nar\/gkx1227","article-title":"CRISPR\/Cas9-mediated modulation of splicing efficiency reveals short splicing isoform of Xist RNA is sufficient to induce X-chromosome inactivation","volume":"46","author":"Yue","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bbrc.2024.150664_bib121","first-page":"3875","article-title":"En bloc and segmental deletions of human XIST reveal X chromosome inactivation-involving RNA elements","volume":"47","author":"Lee","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bbrc.2024.150664_bib122","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1016\/j.cell.2021.02.015","article-title":"B cell-specific XIST complex enforces X-inactivation and restrains atypical B cells","volume":"184","author":"Yu","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.bbrc.2024.150664_bib123","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2021.592571","article-title":"CRISPR gene-editing models geared toward therapy for hereditary and developmental neurological disorders","volume":"9","author":"Wong","year":"2021","journal-title":"Front Pediatr"},{"key":"10.1016\/j.bbrc.2024.150664_bib124","author":"Bansal"},{"key":"10.1016\/j.bbrc.2024.150664_bib125","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1073\/pnas.93.3.1156","article-title":"Hybrid restriction enzymes: zinc finger fusions to Fok I cleavage domain","volume":"93","author":"Kim","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbrc.2024.150664_bib126","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1038\/nbt1125","article-title":"Gene targeting using zinc finger nucleases","volume":"23","author":"Porteus","year":"2005","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.bbrc.2024.150664_bib127","doi-asserted-by":"crossref","first-page":"5978","DOI":"10.1093\/nar\/gki912","article-title":"Zinc finger nucleases: custom-designed molecular scissors for genome engineering of plant and mammalian cells","volume":"33","author":"Durai","year":"2005","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bbrc.2024.150664_bib128","doi-asserted-by":"crossref","first-page":"15022","DOI":"10.1073\/pnas.1009424107","article-title":"Gene targeting by homologous recombination in mouse zygotes mediated by zinc-finger nucleases","volume":"107","author":"Meyer","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbrc.2024.150664_bib129","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1038\/mt.2015.41","article-title":"Excision of expanded GAA repeats alleviates the molecular phenotype of friedreich's ataxia","volume":"23","author":"Li","year":"2015","journal-title":"Mol. Ther."},{"key":"10.1016\/j.bbrc.2024.150664_bib130","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1101\/gr.099747.109","article-title":"Targeted chromosomal deletions in human cells using zinc finger nucleases","volume":"20","author":"Lee","year":"2010","journal-title":"Genome Res."},{"key":"10.1016\/j.bbrc.2024.150664_bib131","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1111\/j.1365-313X.2005.02551.x","article-title":"High-frequency homologous recombination in plants mediated by zinc-finger nucleases","volume":"44","author":"Wright","year":"2005","journal-title":"Plant J."},{"key":"10.1016\/j.bbrc.2024.150664_bib132","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1089\/hum.2011.140","article-title":"Versatile and efficient genome editing in human cells by combining zinc-finger nucleases with adeno-associated viral vectors","volume":"23","author":"H\u00e4ndel","year":"2012","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.bbrc.2024.150664_bib133","doi-asserted-by":"crossref","first-page":"R69","DOI":"10.1186\/gb-2013-14-7-r69","article-title":"A simple strategy for heritable chromosomal deletions in zebrafish via the combinatorial action of targeting nucleases","volume":"14","author":"Lim","year":"2013","journal-title":"Genome Biol."},{"key":"10.1016\/j.bbrc.2024.150664_bib134","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.bbrc.2009.07.112","article-title":"Targeted manipulation of mammalian genomes using designed zinc finger nucleases","volume":"388","author":"Kandavelou","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2024.150664_bib135","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/nrm3486","article-title":"TALENs: a widely applicable technology for targeted genome editing","volume":"14","author":"Joung","year":"2013","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bbrc.2024.150664_bib136","doi-asserted-by":"crossref","DOI":"10.3389\/fgeed.2023.1130736","article-title":"T-CAST: an optimized CAST-Seq pipeline for TALEN confirms superior safety and efficacy of obligate-heterodimeric scaffolds","volume":"5","author":"Rhiel","year":"2023","journal-title":"Front Genome Ed"},{"key":"10.1016\/j.bbrc.2024.150664_bib137","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1042\/BJ20140295","article-title":"TALEN-mediated genome editing: prospects and perspectives","volume":"462","author":"Wright","year":"2014","journal-title":"Biochem. J."},{"key":"10.1016\/j.bbrc.2024.150664_bib138","doi-asserted-by":"crossref","first-page":"17382","DOI":"10.1073\/pnas.1211446109","article-title":"Efficient TALEN-mediated gene knockout in livestock","volume":"109","author":"Carlson","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbrc.2024.150664_bib139","doi-asserted-by":"crossref","first-page":"3632","DOI":"10.1038\/srep03632","article-title":"A robust TALENs system for highly efficient mammalian genome editing","volume":"4","author":"Feng","year":"2014","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbrc.2024.150664_bib140","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/s43141-021-00225-z","article-title":"TALENs-an indispensable tool in the era of CRISPR: a mini review","volume":"19","author":"Bhardwaj","year":"2021","journal-title":"J. Genet. Eng. Biotechnol."},{"key":"10.1016\/j.bbrc.2024.150664_bib141","doi-asserted-by":"crossref","first-page":"302","DOI":"10.3389\/fpls.2017.00302","article-title":"DNA methylation affects the efficiency of transcription activator-like effector nucleases-mediated genome editing in rice","volume":"8","author":"Kaya","year":"2017","journal-title":"Front. Plant Sci."},{"key":"10.1016\/j.bbrc.2024.150664_bib142","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/nm.4313","article-title":"Refining strategies to translate genome editing to the clinic","volume":"23","author":"Cornu","year":"2017","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbrc.2024.150664_bib143","doi-asserted-by":"crossref","first-page":"9283","DOI":"10.1093\/nar\/gkr597","article-title":"A novel TALE nuclease scaffold enables high genome editing activity in combination with low toxicity","volume":"39","author":"Mussolino","year":"2011","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bbrc.2024.150664_bib144","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1016\/j.omtn.2021.08.008","article-title":"The comparison of ZFNs, TALENs, and SpCas9 by GUIDE-seq in HPV-targeted gene therapy","volume":"26","author":"Cui","year":"2021","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.bbrc.2024.150664_bib145","doi-asserted-by":"crossref","first-page":"3453","DOI":"10.1038\/s41467-022-30896-2","article-title":"Endowing universal CAR T-cell with immune-evasive properties using TALEN-gene editing","volume":"13","author":"Jo","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbrc.2024.150664_bib146","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41408-021-00469-5","article-title":"CAR T-cell therapy in multiple myeloma: more room for improvement","volume":"11","author":"Teoh","year":"2021","journal-title":"Blood Cancer J."},{"key":"10.1016\/j.bbrc.2024.150664_bib147","doi-asserted-by":"crossref","first-page":"34671","DOI":"10.1074\/jbc.M113.496174","article-title":"Transcription activator-like effector nuclease (TALEN)-mediated gene correction in integration-free \u03b2-thalassemia induced pluripotent stem cells","volume":"288","author":"Ma","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2024.150664_bib148","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0076004","article-title":"Targeted gene deletion of miRNAs in mice by TALEN system","volume":"8","author":"Takada","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.bbrc.2024.150664_bib149","volume":"vol. 2","author":"Becker","year":"2021"},{"key":"10.1016\/j.bbrc.2024.150664_bib150","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s10577-023-09735-7","article-title":"Modeling specific aneuploidies: from karyotype manipulations to biological insights","volume":"31","author":"Truong","year":"2023","journal-title":"Chromosome Res."},{"key":"10.1016\/j.bbrc.2024.150664_bib151","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.virol.2012.07.021","article-title":"Sequential deletion of genes from the African swine fever virus genome using the cre\/loxP recombination system","volume":"433","author":"Abrams","year":"2012","journal-title":"Virology"},{"key":"10.1016\/j.bbrc.2024.150664_bib152","doi-asserted-by":"crossref","first-page":"147","DOI":"10.5625\/lar.2018.34.4.147","article-title":"Mouse Cre-LoxP system: general principles to determine tissue-specific roles of target genes","volume":"34","author":"Kim","year":"2018","journal-title":"Lab Anim Res"},{"key":"10.1016\/j.bbrc.2024.150664_bib153","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/cpmo.22","article-title":"Cre-loxP-Mediated recombination: general principles and experimental considerations","volume":"7","author":"McLellan","year":"2017","journal-title":"Curr. Protoc. Mol. Biol."},{"key":"10.1016\/j.bbrc.2024.150664_bib154","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.jbiotec.2007.05.027","article-title":"Application of the Cre-loxP system for multiple gene disruption in the yeast Kluyveromyces marxianus","volume":"131","author":"Ribeiro","year":"2007","journal-title":"J. Biotechnol."},{"key":"10.1016\/j.bbrc.2024.150664_bib155","first-page":"F651","article-title":"The Cre\/loxP system and gene targeting in the kidney","volume":"276","author":"Stricklett","year":"1999","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.bbrc.2024.150664_bib156","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1093\/emboj\/21.3.440","article-title":"Transvection effects involving DNA methylation during meiosis in the mouse","volume":"21","author":"Rassoulzadegan","year":"2002","journal-title":"EMBO J."},{"key":"10.1016\/j.bbrc.2024.150664_bib157","doi-asserted-by":"crossref","first-page":"14492","DOI":"10.1073\/pnas.0807484105","article-title":"Recombination between inverted loxP sites is cytotoxic for proliferating cells and provides a simple tool for conditional cell ablation","volume":"105","author":"Gr\u00e9goire","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbrc.2024.150664_bib158","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/ng1097-223","article-title":"Cre-mediated chromosome loss in mice","volume":"17","author":"Lewandoski","year":"1997","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbrc.2024.150664_bib159","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/bmb\/ldw040","article-title":"Mouse-based genetic modeling and analysis of Down syndrome","volume":"120","author":"Xing","year":"2016","journal-title":"Br. Med. Bull."},{"key":"10.1016\/j.bbrc.2024.150664_bib160","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1128\/MCB.20.2.648-655.2000","article-title":"Engineering mouse chromosomes with Cre-loxP: range, efficiency, and somatic applications","volume":"20","author":"Zheng","year":"2000","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.bbrc.2024.150664_bib161","doi-asserted-by":"crossref","first-page":"137","DOI":"10.3390\/biom8040137","article-title":"Genome editing in model strain myxococcus xanthus DK1622 by a site-specific cre\/loxP recombination system","volume":"8","author":"Yang","year":"2018","journal-title":"Biomolecules"},{"key":"10.1016\/j.bbrc.2024.150664_bib162","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.3390\/microorganisms10061240","article-title":"Establishment of a cre-loxP system based on a leaky LAC4 promoter and an unstable panARS element in kluyveromyces marxianus","volume":"10","author":"Ren","year":"2022","journal-title":"Microorganisms"},{"key":"10.1016\/j.bbrc.2024.150664_bib163","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1038\/s41467-021-21427-6","article-title":"Cre-Controlled CRISPR mutagenesis provides fast and easy conditional gene inactivation in zebrafish","volume":"12","author":"Hans","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbrc.2024.150664_bib164","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.omtn.2017.04.018","article-title":"CRISPR\/Cas9-loxP-Mediated gene editing as a novel site-specific genetic manipulation tool","volume":"7","author":"Yang","year":"2017","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.bbrc.2024.150664_bib165","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-49783-w","article-title":"A novel conditional ZsGreen-expressing transgenic reporter rat strain for validating Cre recombinase expression","volume":"9","author":"Bryda","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbrc.2024.150664_bib166","article-title":"Mouse models of Down syndrome: gene content and consequences, Mammalian Genome","volume":"27","author":"M","year":"2016","journal-title":"Official Journal of the International Mammalian Genome Society"},{"key":"10.1016\/j.bbrc.2024.150664_bib167","doi-asserted-by":"crossref","first-page":"6008","DOI":"10.1038\/ncomms7008","article-title":"Dppa3 expression is critical for generation of fully reprogrammed iPS cells and maintenance of Dlk1-Dio3 imprinting","volume":"6","author":"Xu","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbrc.2024.150664_bib168","doi-asserted-by":"crossref","first-page":"211","DOI":"10.3390\/cells12020211","article-title":"Recognizing the differentiation degree of human induced pluripotent stem cell-derived retinal pigment epithelium cells using machine learning and deep learning-based approaches","volume":"12","author":"Lien","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.bbrc.2024.150664_bib169","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1002\/sctm.18-0087","article-title":"Concise review: molecular cytogenetics and quality control: clinical guardians for pluripotent stem cells","volume":"7","author":"Rohani","year":"2018","journal-title":"Stem Cells Transl Med"},{"key":"10.1016\/j.bbrc.2024.150664_bib170","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/nature12923","article-title":"Cell-autonomous correction of ring chromosomes in human induced pluripotent stem cells","volume":"507","author":"Bershteyn","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2024.150664_bib171","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1016\/j.stemcr.2018.03.019","article-title":"X chromosome dosage influences DNA methylation dynamics during reprogramming to mouse iPSCs","volume":"10","author":"Pasque","year":"2018","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.bbrc.2024.150664_bib172","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.stemcr.2014.04.003","article-title":"X Chromosome of female cells shows dynamic changes in status during human somatic cell reprogramming","volume":"2","author":"Kim","year":"2014","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.bbrc.2024.150664_bib173","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.nbd.2018.05.004","article-title":"PCDH19 regulation of neural progenitor cell differentiation suggests asynchrony of neurogenesis as a mechanism contributing to PCDH19 Girls Clustering Epilepsy","volume":"116","author":"Homan","year":"2018","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bbrc.2024.150664_bib174","doi-asserted-by":"crossref","first-page":"e1279","DOI":"10.1002\/mgg3.1279","article-title":"A rare case of NIPT discrepancy caused by the placental mosaicism of three different karyotypes, 47,XXX, 47,XX,+21, and 48,XXX,+21","volume":"8","author":"Li","year":"2020","journal-title":"Mol Genet Genomic Med"},{"key":"10.1016\/j.bbrc.2024.150664_bib175","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1111\/jcmm.16080","article-title":"Chromosomal mosaicism detected by karyotyping and chromosomal microarray analysis in prenatal diagnosis","volume":"25","author":"Zhang","year":"2021","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.bbrc.2024.150664_bib176","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1055\/s-0040-1721076","article-title":"Mosaic trisomy 5: prenatal genetic diagnosis and outcomes of a new case","volume":"12","author":"S\u00e1nchez-Herrero","year":"2023","journal-title":"J. Pediatr. Genet."},{"key":"10.1016\/j.bbrc.2024.150664_bib177","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1126\/science.aam9046","article-title":"Fertile offspring from sterile sex chromosome trisomic mice","volume":"357","author":"Hirota","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.bbrc.2024.150664_bib178","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0264965","article-title":"iPSC reprogramming-mediated aneuploidy correction in autosomal trisomy syndromes","volume":"17","author":"Akutsu","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.bbrc.2024.150664_bib179","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2017.00384","article-title":"Neural progenitor cell polarity and cortical development","volume":"11","author":"Arai","year":"2017","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.bbrc.2024.150664_bib180","doi-asserted-by":"crossref","first-page":"44","DOI":"10.15252\/embr.201439583","article-title":"Stem and progenitor cell dysfunction in human trisomies","volume":"16","author":"Liu","year":"2015","journal-title":"EMBO Rep."},{"key":"10.1016\/j.bbrc.2024.150664_bib181","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1038\/nature12530","article-title":"Usp 16 contributes to somatic stem-cell defects in Down's syndrome","volume":"501","author":"Adorno","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2024.150664_bib182","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.stemcr.2016.08.003","article-title":"Molecular characterization of down syndrome embryonic stem cells reveals a role for RUNX1 in neural differentiation","volume":"7","author":"Halevy","year":"2016","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.bbrc.2024.150664_bib183","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.stem.2016.04.007","article-title":"iPSCs offer a new look at GATA1-trisomy 21 cooperation","volume":"18","author":"McNulty","year":"2016","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.bbrc.2024.150664_bib184","article-title":"Cardiotoxicity induced by antineoplastic drug Daunorubicin and its amelioration: a review of literature","volume":"3","author":"Zorawar","year":"2019","journal-title":"Blood Heart Circ"},{"key":"10.1016\/j.bbrc.2024.150664_bib185","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1111\/bcpt.12606","article-title":"Daunorubicin down-regulates the expression of stem cell markers and factors involved in stem cell migration and homing in rat heart in subchronic but not acute cardiomyopathy","volume":"119","author":"Srankova","year":"2016","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.bbrc.2024.150664_bib186","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1038\/s41591-020-1023-0","article-title":"Polygenic architecture informs potential vulnerability to drug-induced liver injury","volume":"26","author":"Koido","year":"2020","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbrc.2024.150664_bib187","doi-asserted-by":"crossref","DOI":"10.3389\/fgeed.2021.630600","article-title":"Genome editing in iPSC-based neural systems: from disease models to future therapeutic strategies","volume":"3","author":"McTague","year":"2021","journal-title":"Frontiers in Genome Editing"},{"key":"10.1016\/j.bbrc.2024.150664_bib188","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1007\/s11481-019-09849-y","article-title":"Next generation precision medicine: CRISPR-mediated genome editing for the treatment of neurodegenerative disorders","volume":"14","author":"Raikwar","year":"2019","journal-title":"J. Neuroimmune Pharmacol."},{"key":"10.1016\/j.bbrc.2024.150664_bib189","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1002\/pbc.22182","article-title":"Autologous stem cell transplant in a patient with Down syndrome and relapsed Hodgkin lymphoma","volume":"53","author":"Eckrich","year":"2009","journal-title":"Pediatr. Blood Cancer"},{"key":"10.1016\/j.bbrc.2024.150664_bib190","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0036082","article-title":"Effects of neonatal neural progenitor cell implantation on adult neuroanatomy and cognition in the Ts65Dn model of down syndrome","volume":"7","author":"Rachubinski","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.bbrc.2024.150664_bib191","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.exger.2012.06.013","article-title":"Modulating cognitive deficits and tau accumulation in a mouse model of aging Down syndrome through neonatal implantation of neural progenitor cells","volume":"47","author":"Rachubinski","year":"2012","journal-title":"Exp. Gerontol."},{"key":"10.1016\/j.bbrc.2024.150664_bib192","doi-asserted-by":"crossref","first-page":"371","DOI":"10.3727\/096368910X528085","article-title":"Neural stem cells reduce hippocampal tau and reelin accumulation in aged Ts65Dn down syndrome mice","volume":"20","author":"Kern","year":"2011","journal-title":"Cell Transplant."},{"key":"10.1016\/j.bbrc.2024.150664_bib193","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1200\/JCO.2018.77.8084","article-title":"T cells genetically modified to express an anti-B-cell maturation antigen chimeric antigen receptor cause remissions of poor-prognosis relapsed multiple myeloma","volume":"36","author":"Brudno","year":"2018","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bbrc.2024.150664_bib194","doi-asserted-by":"crossref","first-page":"255","DOI":"10.3324\/haematol.2019.243246","article-title":"Impact and safety of chimeric antigen receptor T-cell therapy in older, vulnerable patients with relapsed\/refractory large B-cell lymphoma","volume":"106","author":"Lin","year":"2021","journal-title":"Haematologica"},{"key":"10.1016\/j.bbrc.2024.150664_bib195","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.02486","article-title":"Expanding the therapeutic window for CAR T cell therapy in solid tumors: the knowns and unknowns of CAR T cell biology","volume":"9","author":"Watanabe","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbrc.2024.150664_bib196","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1186\/s12943-020-01282-7","article-title":"Pre-depletion of TRBC1+ T cells promotes the therapeutic efficacy of anti-TRBC1 CAR-T for T-cell malignancies","volume":"19","author":"Zhang","year":"2020","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bbrc.2024.150664_bib197","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/nrclinonc.2017.128","article-title":"Chimeric antigen receptor T-cell therapies for lymphoma","volume":"15","author":"Brudno","year":"2018","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.bbrc.2024.150664_bib198","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1186\/s12887-022-03450-8","article-title":"Blood cytology in children with down syndrome","volume":"22","author":"Garc\u00eda de la Puente","year":"2022","journal-title":"BMC Pediatr."},{"key":"10.1016\/j.bbrc.2024.150664_bib199","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.30002","article-title":"Blood counts in children with Down syndrome","volume":"69","author":"Harvey","year":"2022","journal-title":"Pediatr. Blood Cancer"},{"key":"10.1016\/j.bbrc.2024.150664_bib200","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/ajmg.a.31442","article-title":"Hematological abnormalities during the first week of life among neonates with Down syndrome: data from a multihospital healthcare system","volume":"143A","author":"Henry","year":"2007","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.bbrc.2024.150664_bib201","first-page":"110","article-title":"Bone marrow Ts65Dn trisomy-induced changes in platelet functionality and lymphocytopenia do not impact atherosclerosis susceptibility in mice","volume":"8","author":"Korporaal","year":"2021","journal-title":"J Cardiovasc Dev Dis"},{"key":"10.1016\/j.bbrc.2024.150664_bib202","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1186\/s13287-021-02462-y","article-title":"CAR-engineered NK cells; a promising therapeutic option for treatment of hematological malignancies","volume":"12","author":"Marofi","year":"2021","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.bbrc.2024.150664_bib203","first-page":"1280","article-title":"CTL019 therapy appears safe and effective in pediatric patients with down syndrome with relapsed\/refractory (r\/r) acute lymphoblastic leukemia","volume":"130","author":"Laetsch","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.bbrc.2024.150664_bib204","doi-asserted-by":"crossref","first-page":"4820","DOI":"10.1182\/blood-2021-153262","article-title":"Tisagenlecleucel therapy is safe and effective for children with down syndrome with ALL in first relapse","volume":"138","author":"Krueger","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.bbrc.2024.150664_bib205","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41408-018-0164-6","article-title":"The journey to CAR T cell therapy: the pediatric and young adult experience with relapsed or refractory B-ALL","volume":"9","author":"Hucks","year":"2019","journal-title":"Blood Cancer J."},{"key":"10.1016\/j.bbrc.2024.150664_bib206","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1036455","article-title":"High risk-myelodysplastic syndrome following CAR T-cell therapy in a patient with relapsed diffuse large B cell lymphoma: a case report and literature review","volume":"13","author":"Accorsi Buttini","year":"2023","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bbrc.2024.150664_bib207","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1016\/j.bbmt.2016.12.003","article-title":"Ruxolitinib prevents cytokine release syndrome after car T-cell therapy without impairing the anti-tumor effect in a xenograft model","volume":"23","author":"Kenderian","year":"2017","journal-title":"Biol. Blood Marrow Transplant."},{"key":"10.1016\/j.bbrc.2024.150664_bib208","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1111\/jcmm.16176","article-title":"Ruxolitinib mitigates steroid\u2010refractory CRS during CAR T therapy","volume":"25","author":"Pan","year":"2021","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.bbrc.2024.150664_bib209","doi-asserted-by":"crossref","first-page":"284","DOI":"10.3934\/Neuroscience.2021015","article-title":"From the lab to the people: major challenges in the biological treatment of Down syndrome","volume":"8","author":"Rondal","year":"2021","journal-title":"AIMS Neurosci"},{"key":"10.1016\/j.bbrc.2024.150664_bib210","doi-asserted-by":"crossref","first-page":"e349","DOI":"10.1038\/mtna.2016.58","article-title":"CRISPR-Cas9 for in vivo gene therapy: promise and hurdles","volume":"5","author":"Dai","year":"2016","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.bbrc.2024.150664_bib211","doi-asserted-by":"crossref","first-page":"8891","DOI":"10.3390\/ijms23168891","article-title":"Thermodynamic swings: how ideal complex of cas9-RNA\/DNA forms","volume":"23","author":"Zhdanova","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbrc.2024.150664_bib212","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1080\/10717544.2018.1474964","article-title":"Delivering CRISPR: a review of the challenges and approaches","volume":"25","author":"Lino","year":"2018","journal-title":"Drug Deliv."},{"key":"10.1016\/j.bbrc.2024.150664_bib213","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1038\/s41556-019-0424-0","article-title":"Human germline genome editing","volume":"21","author":"Lea","year":"2019","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.bbrc.2024.150664_bib214","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1038\/s41467-023-36820-6","article-title":"Limitations of gene editing assessments in human preimplantation embryos","volume":"14","author":"Liang","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbrc.2024.150664_bib215","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1002\/cbin.11837","article-title":"Comparison of DNA stability and its related genes of neurons derived from induced pluripotent stem cells and primary retinal neurons","volume":"46","author":"Yu","year":"2022","journal-title":"Cell Biol. Int."},{"key":"10.1016\/j.bbrc.2024.150664_bib216","doi-asserted-by":"crossref","first-page":"9699","DOI":"10.3390\/ijms23179699","article-title":"Treating iPSC-derived \u03b2 cells with an anti-CD30 antibody-drug conjugate eliminates the risk of teratoma development upon transplantation","volume":"23","author":"Pellegrini","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbrc.2024.150664_bib217","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1182\/blood-2020-141249","article-title":"The enhanced functionality of low-affinity CD19 CAR T cells is associated with activation priming and polyfunctional cytokine phenotype","volume":"136","author":"Michelozzi","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.bbrc.2024.150664_bib218","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1182\/bloodadvances.2022008490","article-title":"Activation priming and cytokine polyfunctionality modulate the enhanced functionality of low-affinity CD19 CAR T cells","volume":"7","author":"Michelozzi","year":"2023","journal-title":"Blood Adv"}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X24012002?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X24012002?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,20]],"date-time":"2024-12-20T09:03:57Z","timestamp":1734685437000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X24012002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":218,"alternative-id":["S0006291X24012002"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2024.150664","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chromosomal and cellular therapeutic approaches for Down syndrome: A research update","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2024.150664","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"150664"}}